Ulcerative Colitis Clinical Trials 2022

Browse 119 Ulcerative Colitis Medical Studies Across 386 Cities

29 Phase 3 Trial · 1627 Ulcerative Colitis Clinics

Reviewed by Michael Gill, B. Sc.
25 Ulcerative Colitis Clinical Trials Near Me
Westlake, OH
Orlando, FL
Atlanta, GA
High Point, NC
More Trial Locations
An interactive map to display trial locations for Northshore Gastroenterology Research, LLC, Orlando Health, Emory University, Peters Medical Research, and 268 more locations.
Most Popular References for Ulcerative Colitis Clinical Trials
Frequency
Citation
Top Hospitals for Ulcerative Colitis Clinical Trials
Location
Active Ulcerative Colitis Clinical Trials
All Time Trials for Ulcerative Colitis
First Recorded Ulcerative Colitis Trial
Trials
Tyler Research Institute, LLC, Tyler, Texas
7
16
2012
Vanderbilt University Medical Center, Nashville, Tennessee
7
28
2004
Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan
6
21
2004
Chevy Chase Clinical Research, Chevy Chase, Maryland
6
21
2006
Top Treatments for Ulcerative Colitis Clinical Trials
Treatment Name
Active Ulcerative Colitis Clinical Trials
All Time Trials for Ulcerative Colitis
First Recorded Ulcerative Colitis Trial
Trials
Top Cities for Ulcerative Colitis Clinical Trials
City
Active Ulcerative Colitis Clinical Trials
Top Active Site for Ulcerative Colitis Clinical Trials
Trial List
New York, New York
45
Weill Cornell Medical College
Most Recent Ulcerative Colitis Clinical Trials
Phase 3 Ulcerative Colitis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Pediatric Ulcerative Colitis Clinical Trials
Senior Friendly Ulcerative Colitis Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Ulcerative Colitis
Treatment
Year
Mechanism of Action
Sponsor
Active Ulcerative Colitis Clinical Trials
BBT-401-1S
2021
Bridge Biotherapeutics, Inc.
0
Etrasimod
2019
Etrasimod
Arena Pharmaceuticals
2
ABBV-323 Dose A
2019
Ravagalimab
AbbVie
0
UTTR1147A
2019
Efmarodocokin alfa
Genentech, Inc.
0
Guselkumab Dose 2
2018
Guselkumab
Janssen Research & Development, LLC
1
UTTR1147A
2018
Efmarodocokin alfa
Genentech, Inc.
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 26th, 2021

Last Reviewed: August 29th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.